Founded in 2004, Red Abbey Venture Partners focuses on investing in young companies in the life sciences industry that are developing drugs, devices, and tools. They have invested in a total of 24 life sciences companies and seek to generate superior returns by supporting companies with distinctive technologies. The firm primarily invests in biotechnology, specialty pharmaceutical, medical device, diagnostics, and research tools companies. Red Abbey Venture Partners was formed by Frank A. Bonsal, Jr., Philip Goelet, PhD, Skip Klein, and Matt Zuga.